scholarly journals Is Elevated Red Blood Cell Distribution Width Value a Prognostic Marker in Sepsis Patients?

Author(s):  
Sethuraj Selvaraj ◽  
A. Tumbanatham

Sepsis and its complications are a common cause of infectious disease and death in worldwide. But the infection can be challenges to confirm and there is gold standard methods to confirm it. Red blood cell distribution width (RDW) value frequently measured at every complete blood count. In sepsis the RDW morphology changes are believed to be mainly related to prognosis. RDW has also been studied as an independent variable in different predictive score. We systematically review the articles can RDW be used as prognostic marker in patient with sepsis.

Oncotarget ◽  
2016 ◽  
Vol 7 (22) ◽  
pp. 32846-32853 ◽  
Author(s):  
Monika Podhorecka ◽  
Dorota Halicka ◽  
Agnieszka Szymczyk ◽  
Arkadiusz Macheta ◽  
Sylwia Chocholska ◽  
...  

2019 ◽  
Vol 8 (3) ◽  
pp. 107-112
Author(s):  
Aslı Korur ◽  
Didar Yanardag Acik ◽  
Soner Solmaz ◽  
Cigdem Gereklioglu ◽  
Suheyl Asma ◽  
...  

Aim: Anemia is a public health problem worldwide. Cost effectiveness and efficient use of resources are vitally important. Red blood cell distribution width, which can be obtained from a standard complete blood count, is a measure of the variability in size of circulating erythrocytes. The present study was performed to investigate whether red blood cell distribution width can be used to predict response to iron therapy. Methods: This study was conducted in 50 patients admitted to hematology and family medicine clinics. Complete blood count and reticulocyte count were determined on day 5; complete blood count was examined 1 month after commencement of therapy. Results: Statistically significant differences were detected between hemoglobin levels and red blood cell distribution width values at the time of diagnosis and on day 5 and after 1 month of therapy. A significant positive correlation was found between the increase in red blood cell distribution width and the increase in hemoglobin. Conclusion: Red blood cell distribution width may be used in place of reticulocyte count to predict response to iron therapy. Red blood cell distribution width is the best biomarker for this purpose as a component of complete blood count, and therefore it may be accepted as superior to reticulocyte count.


2017 ◽  
Vol 16 (1) ◽  
Author(s):  
Andrew Xanthopoulos ◽  
Gregory Giamouzis ◽  
Andreas Melidonis ◽  
Takeshi Kitai ◽  
Efi Paraskevopoulou ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-23 ◽  
Author(s):  
Ning Li ◽  
Heng Zhou ◽  
Qizhu Tang

The red blood cell distribution width (RDW) obtained from a standard complete blood count (CBC) is a convenient and inexpensive biochemical parameter representing the variability in size of circulating erythrocytes. Over the past few decades, RDW with mean corpuscular volume (MCV) has been used to identify quite a few hematological system diseases including iron-deficiency anemia and bone marrow dysfunction. In recent years, many clinical studies have proved that the alterations of RDW levels may be associated with the incidence and prognosis in many cardiovascular and cerebrovascular diseases (CVDs). Therefore, early detection and intervention in time of these vascular diseases is critical for delaying their progression. RDW as a new predictive marker and an independent risk factor plays a significant role in assessing the severity and progression of CVDs. However, the mechanisms of the association between RDW and the prognosis of CVDs remain unclear. In this review, we will provide an overview of the representative literatures concerning hypothetical and potential epidemiological associations between RDW and CVDs and discuss the underlying mechanisms.


Sign in / Sign up

Export Citation Format

Share Document